REFERENCES
- AFCAPS/TexCAPS. Air Force/Texas Cornary Atherosclerosis Prevention Study. J. Am. Med. Assoc. 1998; 279: 1615–1622
- American Heart Association. American Heart Association scientific statement: Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1997; 2751–2753
- Bustos C., Hernandez-Presa M., Ortega M., Tunon J., Orterga L., Perez F., Diaz C., Hernandez G., Egido J. HMG-CoA reductase inhibition reduces neointimal inflammation in a rabbit model of atherosclerosis. J. Am. Coll. Cardiol. 1998; 32: 2057–2064, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Chan A., Bhatt D., Chew D., Reginelli J., Schneider J., Topol E., Ellis S. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 2003; 107: 1750–1756, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Chew D., Bhatt D., Robbins M. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001; 104: 992–997, [PUBMED], [INFOTRIEVE]
- Dockery D., Pope A., Xu X. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 1993; 329: 1753–1759, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Dockery D. Epidemiological evidence of cardiovascular effects of particulate air pollution. Environ. Health Perspect. 2001; 1(09(suppl. 4))483–486
- Donaldson K., Stone V., Seaton A., MacNee W. Ambient particle inhalation and the cardiovascular system: Potential mechanisms. Environ. Health Perspect. 2001; 109(suppl. 4)523–527, [PUBMED], [INFOTRIEVE], [CSA]
- Downs J., Clearfield M., Weis S., Whitney E., Shapiro D. R., Beere P. A., Langendorter A., Stein E. A., Kruyer W., Gotto A. M., Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS Air Force/Texas Coronary Atheriosclerosis Prevention Study. JAMA 1998; 279(20)1619–1622, [CROSSREF], [CROSSREF]
- Driscoll K., Carter J., Hassenbein D., Howard B. Cytokines and particle-induced inflammatory cell recruitment. Environ. Health Perspect. 1997; 105(suppl. 5)1159–1164, [PUBMED], [INFOTRIEVE], [CSA]
- Fichtlscherer S., Rosenberger G., Walter D., Breurer S., Dimmler S., Zeiher A. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102: 1000–1006, [PUBMED], [INFOTRIEVE]
- Fu T., Borensztajn J. Macrophage uptake of LDL bound to aggregated C-reactive protein: Possible mechanism of foam cell formation in atherosclerotic lesions. Biochem. J. 2002; 366: 195–201, [PUBMED], [INFOTRIEVE], [CSA]
- Fukumoto Y., Libby P., Rabkin E., Hill C., Enomoto M., Hirouchi Y., Shiomi M., Aikawa M. Statins alter smooth muscle cell accumulation and collagen content on established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 2001; 103: 993, [PUBMED], [INFOTRIEVE]
- Gabay C., Kushner I. Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation. N. Eng. J. Med. 1999; 340: 448–454, [CSA], [CROSSREF], [CROSSREF]
- Goldberg M., Burnett R., Bailar J., Brook J., Bonvolant Y., Tamblyn R., Singh R., Vincent R. The association between daily mortality and ambient air particle pollution in Montreal, Quebec. Environ. Res. 2001; 86: 26–36, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Goldeski J., Verrier R., Koutrakis P. Mechanisms of morbidity and mortality from exposure to ambient air particles. Respir. Reprod. Health Effects Inst. 2000; 91: 5–88
- Gotschlich E., Stetson C. Immunologic cross-reactions among mammalian acute phase proteins. J. Exp. Med. 1960; 11: 141–145
- Gu L., Okada Y., Clinton S. Absence of monocyte chemoattractant protein-1 reduced atherosclerosis in low-density lipoprotein-deficient mice. Mol. Cell. 1998; 2: 275–281, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Hennekens C. H., Dyken M. L., Fuster V. Aspirin as a therapeutic agent in cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1997; 96(8)2751–2753, [PUBMED], [INFOTRIEVE], [CSA]
- Horne B., Muhlstein J., Carlquist J., Bair T., Madsen T., Hart N., Anderson J. Statin therapy, lipid levels, C-reactive Protein and the survival of patients with angiographically severe coronary artery disease. J. Am. Coll. Cardiol. 2000; 36: 1774–1780, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Jialal I., Stein D., Balis D., Grundy S., Adams-Huet B., Devaraj S. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001; 103: 1933–1935, [PUBMED], [INFOTRIEVE]
- Killingsworth C., Alessandrini F., Krishnamurthy G., Catalan P., Paulauskis J., Godleski J. Inflammation, chemokine expression, and death in monocrotaline-treated rats following fuel oil fly ash inhalation. Inhal. Toxicol. 1997; 9: 541–565, [CROSSREF], [CROSSREF]
- Kushner I., Rzewnicki D. Acute phase response. Inflammation: Basic principles and clinical correlates3rd ed. Lippincott, Williams, Wilkins, Baltimore, MD 1999; pp. 317–329
- Kuta A., Baum L. L. C-reactive protein in produced by a small number of normal human peripheral blood lymphocytes. J. Exp. Med. 1986; 164: 321–326, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Levinson S. What is C-reactive protein telling us about coronary artery disease?. Arch. Intern. Med. 2002; 162: 389–392, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Libby P., Ridker P., Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1143, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Mattoli S. Allergen-induced generation of mediators in the mucosa. Environ. Health Perspect. 2001; 1(09(suppl 4))553–557
- Meier-Ewert H., Ridker P., Rifai N. Absence of clinincal diurnal variation of C-reactive protein concentrations in healthy subjects. Clin. Chem. 2001; 47: 426–430, [PUBMED], [INFOTRIEVE], [CSA]
- Mukae H., Vincent R., Quinlan K., English D., Hards J., Hogg J., van Eeden S. The effect of repeated exposure to particulate air pollution (PM_10) on the bone marrow. Am. J. Respir. Crit. Care Med. 2001; 163: 201–209, [PUBMED], [INFOTRIEVE], [CSA]
- Ostadal P., Cepkova M., Alan D. Atherosclerosis and inflammation. Exp. Clin. Cardiol. 2000; 5: 87–89, [CSA]
- Pasceri V., Willerson J., Yeh E. Direct proinflammatory effect of C-reactive protein on human endothelial Cells. Circulation 2000; 102: 2165–2168, [PUBMED], [INFOTRIEVE]
- Peters A., Perz S., Doring A., Steinber J., Koenig W., Wichmann H. Increases in heart rate during an air pollution episode. Am. J. Epidemiol. 1999; 150: 1094–1098, [PUBMED], [INFOTRIEVE], [CSA]
- Peters A., Dockery D., Muller J., Mittleman M. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001a; 103: 2810–2815, [PUBMED], [INFOTRIEVE]
- Peters A., Frohlich M., Doring T., Immervoll H., Wichmann W., Hutchinson M., Pepys M., Koenig W. Particulate air pollution is associated with an acute phase response in men. Eur. Heart J. 2001b; 22: 1198–1204, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Pepys M. C-reactive protein fifty years on. Lancet 1981; 1: 653–657, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Peyser P. Genetic epidemiology of coronary artery disease. Epidemiol. Rev. 1997; 19: 80–90, [PUBMED], [INFOTRIEVE], [CSA]
- Plenge J., Hernandez T., Weil K., Poirier P., Grunwald G., Marcovina S., Eckel R. Simvastatin Lowers C-reactive protein within 14 days. Circulation 2002; 106: 1447–1452, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Pope C. Epidemiology of fine particulate air pollution and human health: Biologic mechanisms and who's at risk?. Environ. Health Perspect. 2000; 108(suppl. 4)713–723, [PUBMED], [INFOTRIEVE], [CSA]
- Pope A., Verrier R., Lovett E., Larson A., Raizenne M., Kanner R., Schwartz J., Villegas G., Gold D., Dockery D. Heart rate variability associated with particulate air pollution. Ame. Heart J. 1999; 138: 890–899, [CSA]
- Ridker P., Cushman M., Stampfer M., Tracy R., Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 1997; 336: 973–979, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Ridker P., Rifai N., Pfeffer M., Sacks F., Moye L., Goldman S., Flaker G., Braunwald E. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998; 98: 839–844, [PUBMED], [INFOTRIEVE], [CSA]
- Ridker P., Hennekens C., Burnig J., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000; 342: 836–843, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Ridker P., Rifai N., Lowenthal S. Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001a; 103: 1191–1193, [PUBMED], [INFOTRIEVE]
- Ridker P., Rifai N., Clearfeild M., Downs J., Weis S., Miles, Gotto A. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N. Engl. J. Med. 2001b; 344: 1959–1965, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Rifai N., Ridker P. High-sensitivity C-reactive protein: A novel and promising marker of coronary heart disease. Clin. Chem. 2001; 47: 403–411, [PUBMED], [INFOTRIEVE], [CSA]
- Seaton A., MacNess W., Donaldson K., Godden D. Particulate air pollution and acute health effects. Lancet 1995; 345: 176–178, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Steel D., Whitehead A. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 1994; 15: 81–88, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Suwa T., Hogg J., Quinlan K., Ohgami A., Vincent R., van Eeden S. Particulate air pollution induces progression of atherosclerosis. J. Am. Coll. Cardiol. 2002; 39: 935–942, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF], [CROSSREF]
- Tan W., Qui D., Liam B., Lee S., Van Eden S., D'yachkova Y., Hogg J. The human bone marrow response to fine particulate air pollution. Am. J. Crit. Care Med. 2000; 161: 1213–1217, [CSA]
- Tyroler H. Coronary heart disease epidemiology in the 21st century. Epidemiol. Rev. 2000; 22: 7–13, [PUBMED], [INFOTRIEVE], [CSA]
- Yeh T., Willerson J. Coming of age of C-reactive protein. Circulation 2003; 107: 370, [PUBMED], [INFOTRIEVE], [CROSSREF], [CROSSREF]
- Zimmerman M., Selzman C., Cothren C., Sorensen A., Raeburn C., Harken A. Diagnostic implications of C-reactive protein. Arch. Surg. 2003; 103: 220–224